So…
	
	
		
			
			
				
					
						
							
						
					
					www.zerohedge.com
				
			
		
	
The report “highlights the potential for recurrent, symptomatic SARS-CoV-2 replication after successful early treatment” with the pill, the researchers said.
A number of others have said they saw renewed symptoms after taking paxlovid.
 ZeroHedge
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
				The report “highlights the potential for recurrent, symptomatic SARS-CoV-2 replication after successful early treatment” with the pill, the researchers said.
A number of others have said they saw renewed symptoms after taking paxlovid.
	
					
				




